How viral and intracellular bacterial pathogens reprogram the metabolism of host cells to allow their intracellular replication

W Eisenreich, T Rudel, J Heesemann… - Frontiers in cellular and …, 2019 - frontiersin.org
Viruses and intracellular bacterial pathogens (IBPs) have in common the need of suitable
host cells for efficient replication and proliferation during infection. In human infections, the …

Infectious threats, the intestinal barrier, and its trojan horse: dysbiosis

S Iacob, DG Iacob - Frontiers in microbiology, 2019 - frontiersin.org
The ecosystem of the gut microbiota consists of diverse intestinal species with multiple
metabolic and immunologic activities and it is closely connected with the intestinal epithelia …

Human oncoviruses and p53 tumor suppressor pathway deregulation at the origin of human cancers

ML Tornesello, C Annunziata, AL Tornesello… - Cancers, 2018 - mdpi.com
Viral oncogenesis is a multistep process largely depending on the complex interplay
between viruses and host factors. The oncoviruses are capable of subverting the cell …

TP53 Gene Therapy as a Potential Treatment for Patients with COVID-19

JB Harford, SS Kim, KF Pirollo, EH Chang - Viruses, 2022 - mdpi.com
SGT-53 is a novel investigational agent that comprises an immunoliposome carrying a
plasmid vector driving expression of the human TP53 gene that encodes wild-type human …

p53: key conductor of all anti-acne therapies

BC Melnik - Journal of Translational Medicine, 2017 - Springer
This review based on translational research predicts that the transcription factor p53 is the
key effector of all anti-acne therapies. All-trans retinoic acid (ATRA) and isotretinoin (13-cis …

How influenza A virus NS1 deals with the ubiquitin system to evade innate immunity

LA Lamotte, L Tafforeau - Viruses, 2021 - mdpi.com
Ubiquitination is a post-translational modification regulating critical cellular processes such
as protein degradation, trafficking and signaling pathways, including activation of the innate …

Guava flavonoid glycosides prevent influenza A virus infection via rescue of P53 activity

H Khalil, AI Abd El Maksoud, T Roshdey… - Journal of medical …, 2019 - Wiley Online Library
Influenza is a highly infectious disease caused by three types of viruses, including influenza
A virus (IAV), influenza B virus, and, rarely, influenza C virus. IAV is a major, global public …

Combining oncolytic virotherapy with p53 tumor suppressor gene therapy

C Bressy, E Hastie, VZ Grdzelishvili - Molecular Therapy-Oncolytics, 2017 - cell.com
Oncolytic virus (OV) therapy utilizes replication-competent viruses to kill cancer cells, leaving
non-malignant cells unharmed. With the first US Food and Drug Administration-approved …

p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production

D Austin, A Baer, L Lundberg, N Shafagati… - PLoS …, 2012 - journals.plos.org
Rift Valley fever virus (RVFV) is an emerging viral zoonosis that is responsible for
devastating outbreaks among livestock and is capable of causing potentially fatal disease in …

The role of p53 in HIV infection

MM Yaseen, NM Abuharfeil, H Darmani - Current HIV/AIDS Reports, 2023 - Springer
Abstract Purpose of Review This review aims to elucidate the multifaceted role of the tumor
suppressor protein p53 in the context of HIV infection. We explore how p53, a pivotal …